65,437 trials
Healthy
Primary: Cmax - Maximum Observed Concentration — 30.196; 30.892 ng/mL
Influenza Vaccines
Primary: Hemagglutination Inhibition (HI) Antibody Titers — 19.5; 13.9; 116.0; 47.1 titer
Healthy
Primary: Cmax - Maximum Observed Concentration — 32.096; 31.753 ng/mL
Healthy
Primary: Cmax - Maximum Observed Concentration — 26.320; 24.927 mcg/mL
Cardiovascular Diseases
Primary: ONTARGET. Composite Endpoint of Cardiovascular Death, Non-fatal Myocardial Infarction, Non-fatal Stroke and Hospitalization for Congestive Heart Failure — 1386; 1423…
Idiopathic Restless Legs Syndrome
Primary: Change From Baseline in International Restless Legs Syndrome (IRLS) Total Score at 6 Weeks — -12.3; -12.5; -11.8 Points on a scale
Healthy
Primary: Cmax - Maximum Observed Concentration — 30.281; 31.512 mcg/mL
Hypercholesterolemia · Coronary Disease
Primary: Change in Low-density-lipoprotein Cholesterol (LDL-C) at 6 Weeks — -26.5; -11.9 percentage change — p=0.0000
Dyslipidemia
Primary: Maximum Severity of Flushing Events During Week 1 of Niacin Extended-release (NER) Treatment — 57; 48; 28; 24 Percentage of Subjects — p=0.010
Chronic Obstructive Pulmonary Disease
Primary: Hospitalization or Emergency Department Visit for COPD
Healthy
Primary: Bioequivalence Based on Cmax for Amoxicillin — 7331.46; 7235.76 ng/mL
Neoplasms · Neoplasms by Site · Urogenital Neoplasms
Primary: Tumor Response — 0; 1; 12; 11 participants
Cervical Intraepithelial Neoplasia · Uterine Neoplasms · Genital Neoplasms, Female
Primary: Tumor Response — 0; 4; 16; 7 participants
Ovarian Cancer · Peritoneal Cancer
Primary: Tumor Response — 1; 9; 17; 18 participants
Osteoarthritis Knee Pain
Primary: Change in Brief Pain Inventory (BPI) 24-hour Average Rating — -1.80; -1.12; -2.47; -1.41 units on a scale — p=<0.001